BIOMARKERS FOR ASSESSING PERIPHERAL NEUROPATHY RESPONSE TO TREATMENT WITH A PROTEASOME INHIBITOR
摘要
The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.
申请公布号
EP2411535(A1)
申请公布日期
2012.02.01
申请号
EP20100712629
申请日期
2010.03.24
申请人
JANSSEN PHARMACEUTICA, N.V.
发明人
COHEN, NADINE;FAVIS, REYNA;LI, QINGQIN;RICCI, DEBORAH;SUN, YU;VAN DE VELDE, HELGI